iShares US Pharmaceuticals ETF
IHE
IHE
125 hedge funds and large institutions have $143M invested in iShares US Pharmaceuticals ETF in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 11 closing their positions.
Holders
125
Holders Change
+3
Holders Change %
+2.46%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
34
Reduced
30
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
EE
1
EWG Elevate
Roseville,
California
|
$6.35M |
2 |
2
Morgan Stanley
New York
|
$13.2M |
3 |
3
Goldman Sachs
New York
|
$5.67M |
4 |
AWS
4
Atria Wealth Solutions
New York
|
$4.17M |
5 |
MFG
5
Merit Financial Group
Alpharetta,
Georgia
|
$3.56M |